Source:http://linkedlifedata.com/resource/pubmed/id/14684325
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0033681,
umls-concept:C0220781,
umls-concept:C0243077,
umls-concept:C0919479,
umls-concept:C1136847,
umls-concept:C1298907,
umls-concept:C1546945,
umls-concept:C1546947,
umls-concept:C1546969,
umls-concept:C1548171,
umls-concept:C1549060,
umls-concept:C1549065,
umls-concept:C1549443,
umls-concept:C1549445,
umls-concept:C1705108,
umls-concept:C1707689,
umls-concept:C1883254
|
pubmed:issue |
1
|
pubmed:dateCreated |
2003-12-19
|
pubmed:abstractText |
A novel series of substituted 3-[3-(aminopropyl)-4,5,6,7-tetrahydro-1H-indol-2-ylmethylene]-1,3-dihydro-indole-2-ones was discovered as potent inhibitors of the non-receptor tyrosine kinase Src and Yes. A structure-activity relationship was developed in order to optimize their potency and selectivity. Syntheses of these compounds are also described herein.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
187-90
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading | |
pubmed:year |
2004
|
pubmed:articleTitle |
Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase.
|
pubmed:affiliation |
Department of Chemistry, SUGEN, Inc., 230 East Grand Avenue, South San Francisco, CA 94080, USA.
|
pubmed:publicationType |
Journal Article
|